We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASX icon
3151
ASE Group
ASX
$103B
$330K ﹤0.01%
52,663
-35,506
-40% -$208K
VAL icon
3152
Valaris
VAL
$5.91B
$330K ﹤0.01%
+4,879
New +$304K
MPV
3153
Barings Participation Investors
MPV
$174M
$330K ﹤0.01%
26,756
MCI
3154
Barings Corporate Investors
MCI
$344M
$329K ﹤0.01%
23,591
-1,915
-8% -$25.8K
WMPN
3155
DELISTED
William Penn Bancorporation Common Stock
WMPN
$329K ﹤0.01%
27,162
FAX
3156
abrdn Asia-Pacific Income Fund
FAX
$600M
$328K ﹤0.01%
20,795
-20,427
-50% -$307K
GLO
3157
Clough Global Opportunities Fund
GLO
$257M
$328K ﹤0.01%
64,659
-4,661
-7% -$26.2K
ATI icon
3158
ATI
ATI
$30.9B
$327K ﹤0.01%
10,957
+3,300
+43% +$96.6K
ADEA icon
3159
Adeia
ADEA
$3.16B
$327K ﹤0.01%
34,501
-67,555
-66% -$687K
GRX
3160
Gabelli Healthcare & Wellness Trust
GRX
$147M
$326K ﹤0.01%
31,716
-2,863
-8% -$28.8K
MEAR icon
3161
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.37B
$326K ﹤0.01%
6,553
-5,573
-46% -$277K
AJXA
3162
DELISTED
Great Ajax Corp.7.25% Convertible Senior Notes due 2024
AJXA
$326K ﹤0.01%
13,600
XMHQ icon
3163
Invesco S&P MidCap Quality ETF
XMHQ
$5.67B
$325K ﹤0.01%
4,709
+557
+13% +$38.8K
CRF
3164
Cornerstone Total Return Fund
CRF
$1.16B
$325K ﹤0.01%
46,627
-9,632
-17% -$74.8K
NAZ icon
3165
Nuveen Arizona Quality Municipal Income Fund
NAZ
$159M
$324K ﹤0.01%
29,053
-3,525
-11% -$42.3K
MORT icon
3166
VanEck Mortgage REIT Income ETF
MORT
$376M
$324K ﹤0.01%
27,761
+16,209
+140% +$195K
MCR
3167
DELISTED
MFS Charter Income Trust
MCR
$324K ﹤0.01%
52,642
-59,049
-53% -$376K
WDI
3168
Western Asset Diversified Income Fund
WDI
$688M
$324K ﹤0.01%
25,486
+12,720
+100% +$164K
FFTY icon
3169
CapForce IBD 50 ETF
FFTY
$80.5M
$323K ﹤0.01%
14,790
-21,315
-59% -$526K
AMRX icon
3170
Amneal Pharmaceuticals
AMRX
$6.02B
$321K ﹤0.01%
161,387
JOBY icon
3171
Joby Aviation
JOBY
$8.17B
$321K ﹤0.01%
95,831
+27,504
+40% +$111K
NEU icon
3172
NewMarket
NEU
$8.72B
$320K ﹤0.01%
1,029
+65
+7% +$20K
DCBO
3173
Docebo
DCBO
$594M
$319K ﹤0.01%
9,616
+2,190
+29% +$65.6K
XHS icon
3174
State Street SPDR S&P Health Care Services ETF
XHS
$207M
$318K ﹤0.01%
3,751
-831
-18% -$73.1K
CAG icon
3175
CALL
Conagra Brands
CAG
$7.39B
$318K ﹤0.01%
79,400
-300
-0.4% -$10.9K

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.